Edition:
United States

Johnson & Johnson (JNJ)

JNJ on New York Consolidated

124.46USD
28 Jul 2016
Change (% chg)

$-0.31 (-0.25%)
Prev Close
$124.77
Open
$124.98
Day's High
$125.00
Day's Low
$124.41
Volume
4,320,313
Avg. Vol
7,106,166
52-wk High
$126.07
52-wk Low
$81.79

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Johnson & Johnson (JNJ-N) 5:58am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates. 27 Jul 2016 Stock Traders Daily 12 20.00
JNJ: Due Diligence Review: Forensic Earnings and Valuation 27 Jul 2016 New Constructs, LLC 10 25.00
Wright Investors Service Comprehensive Report for Johnson & Johnson 24 Jul 2016 Wright Reports 61 75.00
"The Economy Matters" Report for JNJ: the economy's impact on JNJ's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 24 Jul 2016 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for JNJ 23 Jul 2016 ValuEngine, Inc. 11 25.00
Johnson & Johnson 23 Jul 2016 S&P Capital IQ – STARS Reports 11 127.00
Our Economy without Stimulus; forward observations. 22 Jul 2016 Stock Traders Daily 102 20.00
JOHNSON & JOHNSON (JNJ=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 22 Jul 2016 Pechala's Reports 2 25.00
Value Graph: JOHNSON JOHNSON -- JNJ 21 Jul 2016 Ford Investor Services, Inc. 1 12.00
 
Name Age Since Current Position

Alex Gorsky

55 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

58 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

57 2012 Group Worldwide Chairman

Paulus Stoffels

54 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

57 2012 Vice President, General Counsel